awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48114152-8B4C342E-E4A9-44A7-96A3-35ECAC27AD5E
Q48114152-8B4C342E-E4A9-44A7-96A3-35ECAC27AD5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48114152-8B4C342E-E4A9-44A7-96A3-35ECAC27AD5E
Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation.
P2860
Q48114152-8B4C342E-E4A9-44A7-96A3-35ECAC27AD5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48114152-8B4C342E-E4A9-44A7-96A3-35ECAC27AD5E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0eaff0940e6716be9b3fbdb1d9e97f416cb6e686
P2860
PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins